Shuttle Pharmaceuticals Holdings (SHPH) Invested Capital (2025 - 2026)
Shuttle Pharmaceuticals Holdings (SHPH) posted quarterly Invested Capital of $4.4 million for Q1 2026, little changed quarter-over-quarter from $4.4 million in Q4 2025.
Shuttle Pharmaceuticals Holdings (SHPH) Invested Capital (2025 - 2026) Analysis & Trends
Shuttle Pharmaceuticals Holdings' Invested Capital history runs 2 years deep, the most recent figure standing at $4.4 million for Q1 2026.
- In Q1 2026, Invested Capital changed N/A year-over-year to $4.4 million; the TTM figure through Mar 2026 stood at $8.9 million (changed N/A YoY), while the FY2025 annual figure was $4.4 million, changed N/A from the prior year.
- Invested Capital for Q1 2026 stood at $4.4 million, roughly flat from $4.4 million in the prior quarter.
- The five-year high for Invested Capital was $4.4 million in Q4 2025, with the low at $4.4 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | 9.90 Bn |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 4.50 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 3.74 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 1.74 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 73.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 630.00 Mn |
| 10 | Shuttle Pharmaceuticals Holdings | 1.93 Mn | 1.93 Mn | - | 4.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.44 Mn |
| Dec 31, 2025 | 4.44 Mn |